(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer...
Stats | |
---|---|
今日成交量 | 716 440 |
平均成交量 | 959 817 |
市值 | 0.00 |
EPS | $-0.370 ( 2021-11-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.413 |
ATR14 | $0.155 (13.84%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-12-01 | Ecor1 Capital, Llc | Buy | 185 941 | Common Stock |
2021-12-01 | Ecor1 Capital, Llc | Sell | 185 941 | Common Stock |
2021-12-09 | Ecor1 Capital, Llc | Sell | 156 669 | Common Stock |
2021-12-10 | Ecor1 Capital, Llc | Sell | 5 000 000 | Common Stock |
2021-12-10 | Ecor1 Capital, Llc | Sell | 545 000 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 99 transactions |
Buy: 1 597 913 | Sell: 11 234 741 |
音量 相关性
Odonate Therapeutics Inc 相关性 - 货币/商品
Odonate Therapeutics Inc 财务报表
Annual | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-4.57 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-4.57 |
FY | 2019 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-4.05 |
FY | 2018 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-3.64 |
Financial Reports:
No articles found.
Odonate Therapeutics Inc
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。